{"id":"NCT00231283","sponsor":"Cordis Corporation","briefTitle":"NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions","officialTitle":"A Multicenter, Non-Randomized Study of the CYPHER NxT Sirolimus-Eluting Coronary Stent on BX SONIC OVER-THE-WIRE (OTW) Stent Delivery System(SDS)for the Treatment of de Novo Native Coronary Artery Lesions","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-04","primaryCompletion":null,"completion":"2005-07","firstPosted":"2005-10-04","resultsPosted":"2010-03-23","lastUpdate":"2010-04-20"},"enrollment":100,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Coronary Artery Disease"],"interventions":[{"type":"DEVICE","name":"CYPHER NxT SES ON BX SONIC OTW STENT DELIVERY SYSTEM (SDS)","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the effectiveness and safety of the CYPHER NxT Sirolimus-eluting Coronary Stent on the BX SONIC Over-the-Wire (OTW) Stent Delivery System (SDS) in patients with de novo native coronary artery lesions.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved Procedure Success From Post-procedure to Hospital Discharge","timeFrame":"From post-procedure up to hospital discharge","effectByArm":[{"arm":"CYPHER NxT Stent on the BX SONIC OTW SDS","deltaMin":97,"sd":null}],"pValues":[{"comp":"OG000","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":95},"commonTop":["Target Vessel Failure","Target Vessel Revascularization","Target Lesion Revascularization","Myocardial Infarction (Q wave or Non-Q wave)","Emergent CABG"]}}